VAERS reports by lot

Pfizer COVID-19 lot EWO153: VAERS reports

51 VAERS reports list lot EWO153 as a Pfizer COVID-19 vaccine, received between 2021-04-08 and 2023-01-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
51
Reports
8%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6232%
Neurological4021%
Musculoskeletal1910%
Gastrointestinal168%
Dermatological (non-injection-site)158%
Allergic / Anaphylactic116%
Cardiac / Cardiovascular84%
Respiratory84%
Injection-site / Local reaction74%
Autoimmune / Immune-mediated32%
Thrombotic / Hematological21%
Psychiatric / Neuropsychiatric21%
Reproductive / Menstrual21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California8
New Jersey5
Ohio5
Florida4
Tennessee3
Indiana3
Maryland2
Washington2
Massachusetts2
Colorado2
American Samoa1
Iowa1

Reports by month received

2021-0414
2021-059
2021-063
2021-071
2021-088
2021-094
2021-102
2021-113
2021-121
2022-023
2022-041
2022-051
2023-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.